These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 22949344)

  • 21. Mineralocorticoid receptor antagonists for heart failure.
    Richards AM
    Expert Opin Pharmacother; 2011 Dec; 12(18):2801-15. PubMed ID: 22082128
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aldosterone receptor antagonists--how cardiovascular actions may explain their beneficial effects in heart failure.
    Ovaert P; Elliott J; Bernay F; Guillot E; Bardon T
    J Vet Pharmacol Ther; 2010 Apr; 33(2):109-17. PubMed ID: 20444035
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of mineralocorticoid receptor antagonism by eplerenone.
    Hu X; Li S; McMahon EG; Lala DS; Rudolph AE
    Mini Rev Med Chem; 2005 Aug; 5(8):709-18. PubMed ID: 16101407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
    Rossignol P; Ménard J; Fay R; Gustafsson F; Pitt B; Zannad F
    J Am Coll Cardiol; 2011 Nov; 58(19):1958-66. PubMed ID: 22032706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aldosterone antagonists: characteristics, mechanisms of action, pharmacokinetics, indication, contraindication, clinical data, and side effects].
    Yamamoto T
    Nihon Rinsho; 2007 May; 65 Suppl 5():102-6. PubMed ID: 17571373
    [No Abstract]   [Full Text] [Related]  

  • 26. Eplerenone (GD Searle & Co).
    Martin J; Krum H
    Curr Opin Investig Drugs; 2001 Apr; 2(4):521-4. PubMed ID: 11566010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aldosterone receptor antagonists for heart failure: current status, future indications.
    Pitt B; Rajagopalan S
    Cleve Clin J Med; 2006 Mar; 73(3):257-60, 264-8. PubMed ID: 16548448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure.
    Ajani AE; Marwick TH; Krum H
    Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aldosterone as a target in congestive heart failure.
    Rajagopalan S; Pitt B
    Med Clin North Am; 2003 Mar; 87(2):441-57. PubMed ID: 12693733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exciting new drugs on the horizon - eplerenone, a selective aldosterone receptor antagonist (SARA).
    Coats AJ
    Int J Cardiol; 2001 Aug; 80(1):1-4. PubMed ID: 11532539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF).
    Deswal A; Richardson P; Bozkurt B; Mann DL
    J Card Fail; 2011 Aug; 17(8):634-42. PubMed ID: 21807324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eplerenone : a review of its use in left ventricular systolic dysfunction and heart failure after acute myocardial infarction.
    Keating GM; Plosker GL
    Drugs; 2004; 64(23):2689-707. PubMed ID: 15537370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aldosterone-receptor antagonists in heart failure: insights after EMPHASIS-HF.
    Jacob MS; Tang WH
    Curr Heart Fail Rep; 2011 Mar; 8(1):7-13. PubMed ID: 21207206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Cardioprotective effect of aldosterone antagonists for ventricular remodeling].
    Tatsumi T; Matsubara H
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():524-9. PubMed ID: 16897886
    [No Abstract]   [Full Text] [Related]  

  • 35. Optimizing care of heart failure after acute MI with an aldosterone receptor antagonist.
    Verma A; Solomon SD
    Curr Heart Fail Rep; 2007 Dec; 4(4):183-9. PubMed ID: 18221614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aldosterone and volume management in hypertensive heart disease.
    Sica DA
    Semin Nephrol; 2014 May; 34(3):323-32. PubMed ID: 25016402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of aldosterone receptor blockade in the management of cardiovascular disease.
    Liew D; Krum H
    Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eplerenone: cardiovascular protection.
    Brown NJ
    Circulation; 2003 May; 107(19):2512-8. PubMed ID: 12756192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Aldosterone blocker in heart failure: life prolonging even in mild symptoms].
    MMW Fortschr Med; 2010 Dec; 152(48):12-3. PubMed ID: 21226226
    [No Abstract]   [Full Text] [Related]  

  • 40. Eplerenone in mild heart failure.
    Gus M; Fuchs FD
    N Engl J Med; 2011 Apr; 364(14):1370-1; author reply 1372. PubMed ID: 21470019
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.